Needham Maintains Buy on Doximity, Raises Price Target to $90
Needham analyst Scott Berg maintains Doximity (NYSE:DOCS) with a Buy and raises the price target from $62 to $90.
Earnings Scheduled For November 9, 2021
Companies Reporting Before The Bell
• Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter.
• KT (NYSE:KT) is projected to report earnings for its third quarter.
Cramer Recommends To Hold Doximity, Avoid This Industry And Buy This Stock
On CNBC’s “Mad Money Lightning Round," Jim Cramer said that although Doximity Inc (NYSE: DOCS) was a great company, it’s the kind of stock “that people have turne
Cramer Gives His Opinion On Carnival Corp, Doximity And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Carnival Corp (NYSE: CCL) is good, but Norwegian Cruise Line Holdings Ltd (NYSE:
Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring
Biotricity (NASDAQ: BTCY) is reforming the healthcare market as one of the fastest-growing companies in medtech. The company bridges the gap in remote cardiac monitoring, preventive and chronic care management by using the power of IoT (internet of things), wearables, and connected devices.
Analyst Ratings For Doximity
Doximity (NYSE:DOCS) has observed the following analyst ratings within the last quarter:
Morgan Stanley Maintains Equal-Weight on Doximity, Raises Price Target to $71
Morgan Stanley analyst Craig Hettenbach maintains Doximity (NYSE:DOCS) with a Equal-Weight and raises the price target from $52 to $71.
63 Biggest Movers From Yesterday
Gainers
Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume.
45 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Blue Water Acquisition Corp. (NASDAQ: BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of its stockholders on Friday, August 27, 2021.
